Characterization of vertigo and hearing loss in patients with Fabry disease

Abstract Background Fabry Disease (FD) is an X-linked hereditary lysosomal storage disorder which leads to a multisystemic intralysosomal accumulation of globotriaosylceramid (Gb3). Besides prominent renal and cardiac organ involvement, patients commonly complain about vestibulocochlear symptoms lik...

Full description

Bibliographic Details
Main Authors: Maria Köping, Wafaa Shehata-Dieler, Dieter Schneider, Mario Cebulla, Daniel Oder, Jonas Müntze, Peter Nordbeck, Christoph Wanner, Rudolf Hagen, Sebastian P. Schraven
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13023-018-0882-7
id doaj-b9b7c8b5b8d7471790f3fba9ce62557e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Maria Köping
Wafaa Shehata-Dieler
Dieter Schneider
Mario Cebulla
Daniel Oder
Jonas Müntze
Peter Nordbeck
Christoph Wanner
Rudolf Hagen
Sebastian P. Schraven
spellingShingle Maria Köping
Wafaa Shehata-Dieler
Dieter Schneider
Mario Cebulla
Daniel Oder
Jonas Müntze
Peter Nordbeck
Christoph Wanner
Rudolf Hagen
Sebastian P. Schraven
Characterization of vertigo and hearing loss in patients with Fabry disease
Orphanet Journal of Rare Diseases
Fabry disease
Vertigo
VEMP
Cardiomyopathy
Chronic kidney disease
Lysosomal storage disorder
author_facet Maria Köping
Wafaa Shehata-Dieler
Dieter Schneider
Mario Cebulla
Daniel Oder
Jonas Müntze
Peter Nordbeck
Christoph Wanner
Rudolf Hagen
Sebastian P. Schraven
author_sort Maria Köping
title Characterization of vertigo and hearing loss in patients with Fabry disease
title_short Characterization of vertigo and hearing loss in patients with Fabry disease
title_full Characterization of vertigo and hearing loss in patients with Fabry disease
title_fullStr Characterization of vertigo and hearing loss in patients with Fabry disease
title_full_unstemmed Characterization of vertigo and hearing loss in patients with Fabry disease
title_sort characterization of vertigo and hearing loss in patients with fabry disease
publisher BMC
series Orphanet Journal of Rare Diseases
issn 1750-1172
publishDate 2018-08-01
description Abstract Background Fabry Disease (FD) is an X-linked hereditary lysosomal storage disorder which leads to a multisystemic intralysosomal accumulation of globotriaosylceramid (Gb3). Besides prominent renal and cardiac organ involvement, patients commonly complain about vestibulocochlear symptoms like high-frequency hearing loss, tinnitus and vertigo. However, comprehensive data especially on vertigo remain scarce. The aim of this study was to examine the prevalence and characteristics of vertigo and hearing loss in patients with FD, depending on renal and cardiac parameters and get hints about the site and the pattern of the lesions. Methods Single-center study with 57 FD patients. Every patient underwent an oto-rhino-laryngological examination as well as videonystagmography and vestibular evoked myogenic potentials (VEMPs) and audiological measurements using pure tone audiometry and auditory brainstem response audiometry (ABR). Renal function was measured by eGFR, cardiac impairment was graduated by NYHA class. Results More than one out of three patients (35.1%) complained about hearing loss, 54.4% about vertigo and 28.1% about both symptom. In 74% a sensorineural hearing loss of at least 25 dB was found, ABR could exclude any retrocochlear lesion. Caloric testing showed abnormal values in 71.9%, VEMPs were pathological in 68%. A correlation between the side or the shape of hearing loss and pathological vestibular testing could not be revealed. Conclusions Hearing loss and vertigo show a high prevalence in FD. While hearing loss seems due to a cochlear lesion, peripheral vestibular as well as central nervous pathologies cause vertigo. Thus, both the site of lesion and the pathophysiological patterns seem to differ.
topic Fabry disease
Vertigo
VEMP
Cardiomyopathy
Chronic kidney disease
Lysosomal storage disorder
url http://link.springer.com/article/10.1186/s13023-018-0882-7
work_keys_str_mv AT mariakoping characterizationofvertigoandhearinglossinpatientswithfabrydisease
AT wafaashehatadieler characterizationofvertigoandhearinglossinpatientswithfabrydisease
AT dieterschneider characterizationofvertigoandhearinglossinpatientswithfabrydisease
AT mariocebulla characterizationofvertigoandhearinglossinpatientswithfabrydisease
AT danieloder characterizationofvertigoandhearinglossinpatientswithfabrydisease
AT jonasmuntze characterizationofvertigoandhearinglossinpatientswithfabrydisease
AT peternordbeck characterizationofvertigoandhearinglossinpatientswithfabrydisease
AT christophwanner characterizationofvertigoandhearinglossinpatientswithfabrydisease
AT rudolfhagen characterizationofvertigoandhearinglossinpatientswithfabrydisease
AT sebastianpschraven characterizationofvertigoandhearinglossinpatientswithfabrydisease
_version_ 1724929637935480832
spelling doaj-b9b7c8b5b8d7471790f3fba9ce62557e2020-11-25T02:07:48ZengBMCOrphanet Journal of Rare Diseases1750-11722018-08-011311910.1186/s13023-018-0882-7Characterization of vertigo and hearing loss in patients with Fabry diseaseMaria Köping0Wafaa Shehata-Dieler1Dieter Schneider2Mario Cebulla3Daniel Oder4Jonas Müntze5Peter Nordbeck6Christoph Wanner7Rudolf Hagen8Sebastian P. Schraven9Department of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Internal Medicine I, Comprehensive Heart Failure Center (CHFC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Internal Medicine I, Comprehensive Heart Failure Center (CHFC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Internal Medicine I, Comprehensive Heart Failure Center (CHFC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Internal Medicine I, Comprehensive Heart Failure Center (CHFC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Otorhinolaryngology, Head and Neck Surgery “Otto Körner”, University Medical Center RostockAbstract Background Fabry Disease (FD) is an X-linked hereditary lysosomal storage disorder which leads to a multisystemic intralysosomal accumulation of globotriaosylceramid (Gb3). Besides prominent renal and cardiac organ involvement, patients commonly complain about vestibulocochlear symptoms like high-frequency hearing loss, tinnitus and vertigo. However, comprehensive data especially on vertigo remain scarce. The aim of this study was to examine the prevalence and characteristics of vertigo and hearing loss in patients with FD, depending on renal and cardiac parameters and get hints about the site and the pattern of the lesions. Methods Single-center study with 57 FD patients. Every patient underwent an oto-rhino-laryngological examination as well as videonystagmography and vestibular evoked myogenic potentials (VEMPs) and audiological measurements using pure tone audiometry and auditory brainstem response audiometry (ABR). Renal function was measured by eGFR, cardiac impairment was graduated by NYHA class. Results More than one out of three patients (35.1%) complained about hearing loss, 54.4% about vertigo and 28.1% about both symptom. In 74% a sensorineural hearing loss of at least 25 dB was found, ABR could exclude any retrocochlear lesion. Caloric testing showed abnormal values in 71.9%, VEMPs were pathological in 68%. A correlation between the side or the shape of hearing loss and pathological vestibular testing could not be revealed. Conclusions Hearing loss and vertigo show a high prevalence in FD. While hearing loss seems due to a cochlear lesion, peripheral vestibular as well as central nervous pathologies cause vertigo. Thus, both the site of lesion and the pathophysiological patterns seem to differ.http://link.springer.com/article/10.1186/s13023-018-0882-7Fabry diseaseVertigoVEMPCardiomyopathyChronic kidney diseaseLysosomal storage disorder